The effects of buprenorphine/naloxone on the fetus when Employed in pregnant Females are unidentified. Buprenorphine/naloxone didn't surface to trigger structural abnormalities all through animal reports. There was evidence of obstructed labor, fetal death, neonatal death, and developmental delays in animal reports. These outcomes can't be applied